China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund

Stock News

Sep 21

China-Singapore Suzhou Industrial Park Development Group Co., Ltd. (601512.SH) has announced its plan to participate as a limited partner in the Anhui Daotong Yaohui Equity Investment Partnership (Limited Partnership), committing its own funds to the venture, with a maximum contribution of RMB 20 million.

The fund is dedicated to equity investments in the medical device and biotechnology sectors. In the current fundraising round, it aims to attract multiple investors, targeting a total scale not exceeding RMB 1.1 billion, with the final amount subject to actual fundraising results.

The company's capital contribution will not surpass RMB 20 million and will account for no more than 5% of the final target fund's total subscribed capital. This investment aligns with the company's strategic development plan, as it seeks to generate financial returns while optimizing its industrial investment portfolio.

By participating in this fund, the company aims to effectively supplement its park development and operations business chain, reinforce its core operations in this area, and enhance the overall competitiveness of its industrial park development and management capabilities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1126968451"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1126968451\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1126968451?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-21 16:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126968451","market":"nz","top_or_hot":-1,"title":"China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund","media":"Stock News","content":"<p><b>China-Singapore Suzhou Industrial Park Development Group Co., Ltd.</b> (<b>601512.SH</b>) has announced its plan to participate as a limited partner in the Anhui Daotong Yaohui Equity Investment Partnership (Limited Partnership), committing its own funds to the venture, with a maximum contribution of RMB 20 million.<br><br>The fund is dedicated to equity investments in the medical device and biotechnology sectors. In the current fundraising round, it aims to attract multiple investors, targeting a total scale not exceeding RMB 1.1 billion, with the final amount subject to actual fundraising results.<br><br>The company's capital contribution will not surpass RMB 20 million and will account for no more than 5% of the final target fund's total subscribed capital. This investment aligns with the company's strategic development plan, as it seeks to generate financial returns while optimizing its industrial investment portfolio.<br><br>By participating in this fund, the company aims to effectively supplement its park development and operations business chain, reinforce its core operations in this area, and enhance the overall competitiveness of its industrial park development and management capabilities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-21 16:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>China-Singapore Suzhou Industrial Park Development Group Co., Ltd.</b> (<b>601512.SH</b>) has announced its plan to participate as a limited partner in the Anhui Daotong Yaohui Equity Investment Partnership (Limited Partnership), committing its own funds to the venture, with a maximum contribution of RMB 20 million.<br><br>The fund is dedicated to equity investments in the medical device and biotechnology sectors. In the current fundraising round, it aims to attract multiple investors, targeting a total scale not exceeding RMB 1.1 billion, with the final amount subject to actual fundraising results.<br><br>The company's capital contribution will not surpass RMB 20 million and will account for no more than 5% of the final target fund's total subscribed capital. This investment aligns with the company's strategic development plan, as it seeks to generate financial returns while optimizing its industrial investment portfolio.<br><br>By participating in this fund, the company aims to effectively supplement its park development and operations business chain, reinforce its core operations in this area, and enhance the overall competitiveness of its industrial park development and management capabilities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HELX","symbol_name":"Franklin Genomic Advancements ETF","start_time":0,"source_url":"","article_id":"1126968451","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126968451","pubTimestamp":1789979675,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"China-Singapore Suzhou Industrial Park Development Group Co., Ltd. (601512.SH) has announced its plan to participate as a limited partner in the Anhui Daotong Yaohui Equity Investment Partnership...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","601512":"中新集团","HELX":"Franklin Genomic Advancements ETF","MDEV":"First Trust Indxx Medical Devices ETF","MEDX":"HORIZON KINETICS MEDICAL ETF","LGHT":"LANGAR GLOBAL HEALTHTECH ETF","BK0273":"房地产","WDNA":"WisdomTree BioRevolution Fund","IEIH":"iShares Evolved U.S. Innovative Healthcare ETF","HART":"NYLI Healthy Hearts ETF","GDOC":"Goldman Sachs Future Health Care Equity ETF","BK1100":"医疗保健设备","BK1574":"生物医药B类股","AGNG":"Global X Aging Population ETF","09996":"沛嘉医疗-B","BK1583":"高瓴概念","RSPH":"Invesco S&P 500 Equal Weight Health Care ETF","PTH":"Invesco Dorsey Wright Healthcare Momentum ETF","LNGR":"Global X Longevity Thematic ETF"},"translate_title":"中新苏州工业园区向医疗器械和生物技术基金投资高达2000万元人民币","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"601512":1,"09996":1,"WDNA":1,"RSPH":1,"HELX":1,"PTH":1,"HART":1,"MEDX":1,"LGHT":1,"IEIH":1,"MDEV":1,"AGNG":1,"GDOC":1,"LNGR":1},"content_text":"China-Singapore Suzhou Industrial Park Development Group Co., Ltd. (601512.SH) has announced its plan to participate as a limited partner in the Anhui Daotong Yaohui Equity Investment Partnership (Limited Partnership), committing its own funds to the venture, with a maximum contribution of RMB 20 million.The fund is dedicated to equity investments in the medical device and biotechnology sectors. In the current fundraising round, it aims to attract multiple investors, targeting a total scale not exceeding RMB 1.1 billion, with the final amount subject to actual fundraising results.The company's capital contribution will not surpass RMB 20 million and will account for no more than 5% of the final target fund's total subscribed capital. This investment aligns with the company's strategic development plan, as it seeks to generate financial returns while optimizing its industrial investment portfolio.By participating in this fund, the company aims to effectively supplement its park development and operations business chain, reinforce its core operations in this area, and enhance the overall competitiveness of its industrial park development and management capabilities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}